(Q47845842)

6 February 2018

title

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

0 references

1 reference

1 reference

4

1 reference

6 February 2018

Eleanor Riley

5

object named as

E M Riley

1 reference

6 February 2018

author name string

A F Egan

1

1 reference

6 February 2018

P Burghaus

2

1 reference

6 February 2018

P Druilhe

3

1 reference

6 February 2018

publication date

1 March 1999

1 reference

6 February 2018

published in

Parasite Immunology

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

133-139

1 reference

6 February 2018

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Merozoite surface antigen-I of plasmodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

The major merozoite surface protein as a malaria vaccine target

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

What is the function of MSP-I on the malaria merozoite?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00209.X

10.1046/J.1365-3024.1999.00209.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018